Nina Lass1, Michaela Kleber, Katrin Winkel, Rainer Wunsch, Thomas Reinehr. 1. Department of Pediatric Endocrinology, Diabetes, and Nutrition Medicine, Vestische Hospital for Children and Adolescents, University of Witten/Herdecke, Dr. F. Steiner Strasse 5, D-45711 Datteln, Germany.
Abstract
CONTEXT: Polycystic ovarian syndrome (PCOS) is associated with cardiovascular risk factors (CRF). Lifestyle intervention is regarded as therapy of choice even if studies in adolescent girls with PCOS are scarce. OBJECTIVE: Our objective was to analyze the impact of lifestyle intervention on menses irregularities, hyperandrogenemia, CRF, and intima-media thickness (IMT) in adolescent girls with PCOS. PATIENTS: Patients included 59 obese girls with PCOS aged 12-18 yr. INTERVENTION: Intervention was a 1-yr lifestyle intervention based on nutrition education, exercise training, and behavior therapy. MAIN OUTCOME MEASURES: Menses cycles, IMT, waist circumference, blood pressure, fasting lipids, insulin, glucose, testosterone, dehydroepiandrosterone sulfate, androstenedione, and SHBG were evaluated. RESULTS: In contrast to the 33 girls without weight loss, the 26 girls reducing their body mass index during the lifestyle intervention (by a mean of -3.9 kg/m(2)) improved most CRF and decreased their IMT (by a mean of -0.01 cm). Testosterone concentrations decreased (by a mean of -0.3 nmol/liter) and SHBG concentrations increased (by a mean of +8 ng/ml) significantly in girls with weight loss in contrast to girls with increasing weight. The prevalence of amenorrhea (-42%) and oligoamenorrhea (-19%) decreased in the girls with weight loss. The changes in insulin in the 1-yr follow-up were significantly correlated to changes in testosterone (r = 0.38; P = 0.002) and SHBG (r = -0.35; P = 0.048). A linear regression model with changes in IMT as dependent variable demonstrated a significant association with changes in blood pressure and weight status but not with changes in testosterone. CONCLUSIONS: Weight loss due to lifestyle intervention is effective to treat menses irregularities, normalize androgens, and improve CRF and IMT in obese adolescent girls with PCOS.
CONTEXT: Polycystic ovarian syndrome (PCOS) is associated with cardiovascular risk factors (CRF). Lifestyle intervention is regarded as therapy of choice even if studies in adolescent girls with PCOS are scarce. OBJECTIVE: Our objective was to analyze the impact of lifestyle intervention on menses irregularities, hyperandrogenemia, CRF, and intima-media thickness (IMT) in adolescent girls with PCOS. PATIENTS: Patients included 59 obesegirls with PCOS aged 12-18 yr. INTERVENTION: Intervention was a 1-yr lifestyle intervention based on nutrition education, exercise training, and behavior therapy. MAIN OUTCOME MEASURES: Menses cycles, IMT, waist circumference, blood pressure, fasting lipids, insulin, glucose, testosterone, dehydroepiandrosterone sulfate, androstenedione, and SHBG were evaluated. RESULTS: In contrast to the 33 girls without weight loss, the 26 girls reducing their body mass index during the lifestyle intervention (by a mean of -3.9 kg/m(2)) improved most CRF and decreased their IMT (by a mean of -0.01 cm). Testosterone concentrations decreased (by a mean of -0.3 nmol/liter) and SHBG concentrations increased (by a mean of +8 ng/ml) significantly in girls with weight loss in contrast to girls with increasing weight. The prevalence of amenorrhea (-42%) and oligoamenorrhea (-19%) decreased in the girls with weight loss. The changes in insulin in the 1-yr follow-up were significantly correlated to changes in testosterone (r = 0.38; P = 0.002) and SHBG (r = -0.35; P = 0.048). A linear regression model with changes in IMT as dependent variable demonstrated a significant association with changes in blood pressure and weight status but not with changes in testosterone. CONCLUSIONS:Weight loss due to lifestyle intervention is effective to treat menses irregularities, normalize androgens, and improve CRF and IMT in obese adolescent girls with PCOS.
Authors: E S Barrett; K M Hoeger; S Sathyanarayana; D H Abbott; J B Redmon; R H N Nguyen; S H Swan Journal: J Dev Orig Health Dis Date: 2018-01-09 Impact factor: 2.401
Authors: Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green Journal: Vasc Med Date: 2017-01-17 Impact factor: 3.239
Authors: Catherine Kim; Shengchun Kong; Gail A Laughlin; Sherita H Golden; Kieren J Mather; Bin Nan; Sharon L Edelstein; John F Randolph; Fernand Labrie; Elizabeth Buschur; Elizabeth Barrett-Connor Journal: J Clin Endocrinol Metab Date: 2012-06-11 Impact factor: 5.958
Authors: J M W Wong; M Gallagher; H Gooding; H A Feldman; C M Gordon; D S Ludwig; C B Ebbeling Journal: Pediatr Obes Date: 2015-07-01 Impact factor: 4.000
Authors: Kara S Hughan; Hala Tfayli; Julia G Warren-Ulanch; Emma Barinas-Mitchell; Silva A Arslanian Journal: J Pediatr Date: 2015-11-03 Impact factor: 4.406